End Stage Renal Disease Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Global End-Stage Renal Disease (ESRD) Market Report is Segmented by Treatment (Kidney Transplantation and Dialysis), Diagnosis (Blood Test, Urine Test, Imaging Test, and Other Diagnoses), and Geography (North America (US, Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and Rest of Middle East and Africa), and South America Brazil, Argentina, and Rest of South America)). The report offers value (in USD) for the above segments.

End Stage Renal Disease Market Size

End-stage Renal Disease Market Summary

End Stage Renal Disease Market Analysis

The End-stage Renal Disease Market is expected to register a CAGR of 10% during the forecast period.

The COVID-19 pandemic forced unprecedented changes in the daily life of people. Many patients were under lockdown during this time, and the nephrology community was forced to adapt quickly to this new reality. Patients on dialysis were at high risk of COVID-19 exposure due to the widespread use of public transportation and densely packed clinical spaces. For instance, according to an article published by Karger in June 2022, chronic hemodialysis (HD) patients were considered at high risk of severe COVID-19 with an increased risk of death, and the constraints during the pandemic had an impact on the dialysis delivery to COVID-free hemodialysis patients. Thus the COVID-19 pandemic had a significant effect on the current market initially. However, post-pandemic, the market studied is expected to grow significantly during the forecast period.

The end-stage renal disease market is driven by the increasing number of patients suffering from chronic kidney disease. According to the article published by PubMed Central in April 2022, approximately 10% of the global population suffers from chronic kidney disease, and millions die each year. According to the same article, the rate of patients with chronic kidney disease is increasing.

Another factor is the introduction of technologically advanced products, like low-maintenance dialysis equipment and artificial kidney. In March 2021, Baxter International Inc. announced the United States FDA clearance of its next-generation Artificial Kidney 98 dialysis machine, designed to be a portable and easy-to-use system to administer hemodialysis (HD) treatments. This indicated that companies are taking initiatives to establish a strong footprint and launch technologically advanced products in the market.

Additionally, there is a higher prevalence rate for diabetes, which leads to cause end-stage renal disease in the long run, which may drive the market growth. According to the International Diabetes Federation, in 2021, around 537 million adults (20-79 years) were living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 by 2045. Diabetes is one of the leading causes of kidney failure, which is likely to drive the market's growth over the forecast period.

Therefore, owing to the factors mentioned above, such as the rising prevalence of diabetes and the introduction of technologically advanced products, the market studied is anticipated to witness growth over the analysis period. However, the delay in diagnosing chronic kidney disease may restrain the market growth over the forecast period.

End Stage Renal Disease Industry Overview

The market studied is fragmented due to the presence of many major market players. Market players adopt the strategies, such as organic growth strategies (treatment type launches, treatment type approvals) and others (such as patents and events), which are prioritized by corporations with inorganic growth strategies, like acquisitions, partnerships, and collaborations. Some market players are Nipro Corporation, Fresenius SE & Co. KGaA, Baxter International Inc., Medtronic PLC, B. Braun SE, Asahi Kasei Medical Co. Ltd, Cantel Medical, Nikkiso Co., etc.

End Stage Renal Disease Market Leaders

  1. Nipro Corporation

  2. Fresenius SE & Co. KGaA

  3. Baxter International Inc

  4. Medtronic PLC

  5. B. Braun SE

  6. *Disclaimer: Major Players sorted in no particular order
End-stage Renal Disease Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

End Stage Renal Disease Market News

  • April 2022- Fresenius Medical Care announced that the United States FDA approved the Versi PD Cycler System. It is a next-generation portable automated peritoneal dialysis system approved in North America.
  • March 2022- The Health Minister launched a Hemodialysis unit at New Souillac in the presence of the World Health Representative to mark world kidney day in Mauritius. This new unit comprises 22 hemodialysis machines that can accommodate around 150 patients and aims at further decentralizing the treatment of patients suffering from Kidney disease.

End Stage Renal Disease Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Number of Patient Suffering from Chronic Kidney Disease
    • 4.2.2 Introduction of Technologically Advanced Products
    • 4.2.3 Rising Prevalence of Diabetes and Hypertension
  • 4.3 Market Restraints
    • 4.3.1 Delay in Diagnosis of the Chronic Kidney Disease
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value in USD million)

  • 5.1 By Treatment
    • 5.1.1 Kidney Transplantation
    • 5.1.2 Dialysis
  • 5.2 By Diagnosis
    • 5.2.1 Blood Test
    • 5.2.2 Urine Test
    • 5.2.3 Imaging Test
    • 5.2.4 Other Diagnoses
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Nipro Corporation
    • 6.1.2 Fresenius SE & Co. KGaA
    • 6.1.3 Baxter International Inc.
    • 6.1.4 Medtronic PLC
    • 6.1.5 B. Braun SE
    • 6.1.6 Asahi Kasei Medical Co. Ltd
    • 6.1.7 Cantel Medical (STERIS)
    • 6.1.8 Nikkiso Co. Ltd
    • 6.1.9 Becton, Dickinson and Company
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers - Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

End Stage Renal Disease Industry Segmentation

End-stage renal failure, also known as an end-stage renal disease (ESRD), is the final, permanent stage of chronic kidney disease, where kidneys can no longer function independently. 

The End-stage Renal Disease Market is Segmented by Treatment (Kidney Transplantation and Dialysis), Diagnosis (Blood Test, Urine Test, Imaging Test, and Other Diagnoses), and Geography (North America (United States, Canada, and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and Rest of Middle East and Africa), and South America Brazil, Argentina, and Rest of South America)). The report offers value (in USD million) for the above segments.

By Treatment Kidney Transplantation
Dialysis
By Diagnosis Blood Test
Urine Test
Imaging Test
Other Diagnoses
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

End Stage Renal Disease Market Research FAQs

What is the current End-stage Renal Disease Market size?

The End-stage Renal Disease Market is projected to register a CAGR of 10% during the forecast period (2025-2030)

Who are the key players in End-stage Renal Disease Market?

Nipro Corporation, Fresenius SE & Co. KGaA, Baxter International Inc, Medtronic PLC and B. Braun SE are the major companies operating in the End-stage Renal Disease Market.

Which is the fastest growing region in End-stage Renal Disease Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in End-stage Renal Disease Market?

In 2025, the North America accounts for the largest market share in End-stage Renal Disease Market.

What years does this End-stage Renal Disease Market cover?

The report covers the End-stage Renal Disease Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the End-stage Renal Disease Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

End-Stage Renal Disease Industry Report

Statistics for the 2025 End-stage Renal Disease market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. End-stage Renal Disease analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

End-Stage Renal Disease Market Report Snapshots

Compare market size and growth of End-stage Renal Disease Market with other markets in Healthcare Industry

End Stage Renal Disease Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)